Press Releases

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009

DFINE® ANNOUNCES FIRST PATIENTS Enrolled in THE STARRT™ CLINICAL STUDY ON SPINAL TUMOR ABLATION WITH THE STAR TUMOR ABLATION SYSTEM™

San Jose, Calif.– Jan 19, 2014 -DFINE, Inc., a market leader in the minimally invasive treatment of spinal diseases, today announced that the first two patients have been enrolled in the STARRT Clinical Trial at Providence Sacred Heart Medical Center, Spokane WA.
Read More


DFINE ANNOUNCES COMMENCEMENT OF CLINICAL STUDY ON SPINAL TUMOR ABLATION WITH THE STAR TUMOR ABLATION SYSTEM

San Jose, Calif. and Magdeburg, Germany – June 11, 2014 - DFINE®, Inc., a market leader in the minimally invasive treatment of spinal diseases, today announced that the first patient has been enrolled in the EU-STAR Clinical Trial. The multi-center trial is the first prospective study to evaluate clinical outcomes in patients receiving treatment with the STAR™ Tumor Ablation System for the palliative treatment of metastatic spinal tumors.
Read More


MULTI-CENTER TRIAL SHOWS SIGNIFICANT PAIN RELIEF FOR SPINE CANCER PATIENTS FOLLOWING TARGETED RADIOFREQUENCY ABLATION TREATMENT

SAN JOSE, Calif. – July 21, 2014 - DFINE®, Inc., a market leader in the minimally
invasive treatment of spinal diseases, today announced the publication of a multi-center
study in the July/August issue of Pain Physician Journal, the official peer-reviewed
publication of the American Society of Interventional Pain Physicians (ASIPP).
Read More